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Abstract 
 Fifty years after the work of Anfinsen, we are still unable to definitively determine the 
tertiary structure of proteins from their sequences.  While it is true that recent computational 
studies have shown promising results, it is still very difficult to conclude whether a given 
sequence will fold at all, let alone predict its conformation.  Experimental approaches to the 
protein folding problem allow us to improve upon computational models by obtaining physical 
data on how specific residue mutations affect structure, function, and stability. 
 The four-helix bundle rop was chosen for our studies.  Rop is a small protein with an 
abundance of high-resolution data, making it an ideal choice for site-directed mutagenesis 
experiments.  Additionally, an in vivo screen which uses GFP as a reporter exists for rop. 
 We first set out to create a cysteine-free variant of rop that behaves like the wild-type in 
structure, function, and stability.  After testing several mutants that replace the two cysteines 
with similar residues, it was found that the A38/V52 variant was functionally active, expressed 
well in solution, and possessed a high degree of α-helical content.  15N-HSQC NMR data of this 
A38/V52 mutant showed a peak dispersion that was very similar to wild-type.  Preliminary x-ray 
crystallographic data indicates that this cys-free mutant deviates from wild-type by 0.37 Å. 
 A new method for purifying and screening protein library variants on a high-throughput 
scale was developed.  The purification method takes advantage of recent developments in high-
throughput protein manipulation tools, and the screening method is able to inexpensively screen 
almost one hundred variants at once for stability. 
 Two single-chain rop constructs were designed with the intent to create a single-chain 
monomer that mimicked the structure and function of wild-type rop, which is normally a dimer.  
Both constructs were found to be functionally active.  Further characterization is in progress.  
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Introduction 
Feats of folding 
Christian Anfinsen’s groundbreaking work on ribonuclease in the 1950’s definitively 
linked protein sequence to tertiary structure.1  Denaturing the protein fully with urea ensured that 
no other factors would influence its subsequent refolding.  Upon removal of the denaturant and 
addition of a catalytic amount of reducing agent, the RNase was able to assume its original 
conformation.  This established that the amino acid sequence of a protein is the sole determinant 
of its final conformation in solution.  Hence, each residue presumably contributes in some way to 
a protein’s biophysical properties, including structure and stability.  Anfinsen’s work certainly 
advanced our understanding of protein science; knowing that nature only needs a residue 
sequence to generate a tertiary structure meant that the goal of predicting structures was a 
tangible one.  However, it also meant that a host of new questions would have to be answered. 
For example, how does residue sequence govern protein folding, and how does this 
folding occur in a finite period of time?  Proteins can theoretically assume an almost infinite 
number of conformations, yet they could not possibly try all of them.  This dilemma is 
commonly known as Levinthal’s paradox, named after Cryus Levinthal who posited the issue in 
the 1960’s.2  In fact, proteins in nature fold in fractions of a second, likely through a folding 
“funnel ” which iteratively leads to structures in their lowest energy conformations.3  This begets 
another question of how much information is encoded in any particular residue.  Do some 
positions in a sequence “contribute” more to a structure than others?  Perhaps a more immediate 
question is, what are the forces that act upon amino acids during folding?  These questions are 
encompassed in what is commonly known as the protein folding problem. Active research in 
these areas is done with the expectation to one day be able to accurately predict protein structures 
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from their respective sequences.  Although considerable progress has been made towards 
answering these questions, much work still remains. 
The energetics of protein folding are complex and beyond the scope of this text.  
However, a brief overview is reasonable to explain other topics covered.  The hydrophobic core 
of a globular protein is central to its folding.4  Nonpolar sidechains of hydrophobic residues seek 
to remove themselves from water to obtain a favorable, spontaneous change in free energy by 
interacting with other nonpolar groups.  A group of these nonpolar sidechains which bury 
themselves within the protein constitutes the hydrophobic core.  The resultant van der Waals 
forces inside this hydrophobic core appear to contribute to the protein’s stability.5, 6  
Surprisingly, a protein is only marginally stable; the large, opposing factors of enthalpy and 
entropy virtually cancel out each other in a well-folded protein to yield a very small free energy 
value.4 
Approaches 
There are two principle methods of studying protein folding today: experimental and 
computational.  The latter has emerged as a powerful tool in recent years.7  Dahiyat and Mayo8 
reported the computational design of a protein sequence not found in nature whose NMR 
structure closely resembled its predicted structure.  This was accomplished by using algorithms 
to find a sequence that would fold into a desired backbone configuration, in this case a ββα 
motif.  Harbury et al. used computational methods to design right-handed alpha-helical structures 
not found in nature.9  Instead of using a rigid backbone, though, a different approach was used to 
take into account both main chain flexibility and side chain packing interactions.  More recently, 
Kuhlman et al. used the program Rosetta to computationally design a novel fold using energy 
minimization and optimization.10  The resultant protein crystal structure deviated from the 
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predicted structure by 1.2 Å. 
Experimental methods in protein science are based largely on analyzing the structural 
effects of residue mutations, or site-directed mutagenesis.  As mentioned before, the folding of 
proteins is a delicate energetic balancing act.  It is still difficult for even the best computational 
algorithms to calculate large enthalpic and entropic values to such a high degree of accuracy that 
the resulting free energy value does not have a larger margin of error than the value itself.  
Hence, studying proteins directly is an excellent way to investigate the driving forces of protein 
folding, which could help refine computational methods.  Hecht and Sauer’s report over two 
decades ago illustrated the different consequences of mutating solvent exposed residues versus 
those within the hydrophobic core.11  The authors made over fifty point mutations of λ repressor 
and found that, while surface residue mutations did not substantially alter its overall folding and 
stability, they did seem to adversely affect its ability to bind DNA.  Conversely, mutating core 
residues did appear to affect packing and folding.  Five years later, Lim and Sauer reported the 
successful repacking of λ-repressor’s hydrophobic core.12  Their experiments revealed that 
nonpolar residues could largely only be replaced by like residues (Ala, Val, Ile, Leu, Met, Phe).  
Cysteine, threonine, and serine were also mildly tolerated in some locations, which was thought 
to be due to their hydrogen bonding abilities.  Later, the authors characterized several λ repressor 
variants with hydrophobic core mutations.13  These mutations were intentionally “disruptive,” 
conferring a drastic change in either core volume or hydrophobic character.  They found that 
these mutations often induced changes in both structure and stability. 
Libraries 
Protein folding studies have been aided tremendously by advances in library synthesis 
and screening.  Libraries are already heavily used in small molecule and peptide drug lead 
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discovery14 as well as for finding novel protein binding partners.15  The latter aim has been 
facilitated greatly by solid phase peptide synthesis,16 which has allowed the automated synthesis 
of very large libraries.  In the realm of molecular biology, phage display has proven to be an 
excellent method to be able to quickly screen peptide libraries and establish a “physical linkage 
between phenotype and genotype,”17 which greatly expedites sequence identification.  Libraries 
of larger proteins can be cloned directly into vectors and transformed into cells for screening.18  
This shift from direct synthesis to in-cell synthesis via genetic transcription and translation was 
made possible by the use of nucleotide mixes in oligonucleotide synthesis.19, 20  By introducing 
an equimolar mix of more than one nucleotide type into a reaction vessel during a synthesis step, 
the resultant oligonucleotides are extended by one of up to four different bases.  Hence, the genes 
made using this oligonucleotide may differ in this region.  Using nucleotide mixes in several 
locations rapidly increases the diversity of the subsequent library.  Doing so in a rational fashion 
allows the incorporation of only certain types of residues (hydrophobes, for example).  This has 
obvious applications in experiments which require such stringency: core repacking, for 
example.21  Libraries that randomize all or part of the hydrophobic core can yield extremely 
useful insight into the underpinnings of protein folding. 
Screening 
The abundance of library construction methods has facilitated the rapid synthesis of diverse 
libraries.22  The bottleneck now lies in screening these libraries on a high-throughput scale; 
traditional methods such as circular dichroism (CD) and NMR spectroscopies, while well-studied, 
are simply unable to process a large number of proteins in a reasonable time frame.  Both require 
preparations on the order of 1 L cell culture, and some versions of NMR spectroscopy entail atomic 
labelling.  Characterizing ten variants by these methods is difficult, let alone libraries that are 
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several orders of magnitude larger.  A number of methods have emerged to meet this need for high-
throughput characterization.  Crystallography has seen steady progress, permitting automated, high-
density microtray preparation and micron-size crystal diffraction.23  Additionally, crystallographic 
software has improved dramatically; some programs now permit automatic molecular replacement 
and molecule building.24  This can be especially useful for characterizing variants whose wild-type 
crystal structures have already been solved. 
Edgell and colleagues25 established fluorescence as a viable option for high-throughput 
characterization by using a titrating fluorometer to monitor the unfolding of eglin c mutants.  This 
dual-channel fluorometer slowly combined chemical denaturant with protein while measuring 
intrinsic fluorescence.  The throughput was reported to be approximately 20 min per protein.  A 
major drawback to this method was its reliance on side chain aromatic groups to measure 
fluorescence.  Thus, proteins without Tyr or Trp residues could not be screened.   
This work was followed by the development of ThermoFluor, a method used to assess 
ligand binding by thermal denaturation of protein variants in the presence of a fluorescent dye.26 
Upon exposure to the protein’s hydrophobic core, the dye experiences an increase in quantum 
yield.27, 28  Hence, the unfolding of the protein can be monitored by fluorescence.  Unlike the 
method described by Edgell, this was protein-independent because of its use of a reporter dye 
instead of intrisic fluorescence.  Particularly noteworthy of ThermoFluor was that it used a CCD 
camera to analyze separately each well of a 96-well plate, making it possible to screen 
approximately 3000 compounds in a timely fashion. 
Recently, a Thermofluor-based method has emerged to serve a host of functions.  Lo et al. 
used an RT-PCR machine and a commercially available dye, SYPRO Orange, to assess the ligand 
binding of BACE1 protein.29  The methodology behind this technique is identical to that of 
 11
Thermofluor:  the thermal unfolding of a protein is reported by a hydrophobic dye.  Ericsson et al. 
used this new method to find buffers and additives that would stabilize proteins in order to increase 
their propensity to crystallize.30  The same was true for Yeh et al. with membrane proteins.31  
Vedadi et al. aimed for the same result, but used different ligands instead of conditions.32 
De novo design 
An important tool in advancing our understanding of protein folding is de novo design.  It 
allows us to benchmark how well we can correlate sequence to tertiary structure at our present level 
of understanding.  Regan and DeGrado used a bottom-up approach to design a non-natural protein 
with a four-helix bundle motif.33  This specific motif is popular in de novo studies in part because its 
α-helical content can be measured directly by CD spectroscopy.  In an iterative approach taken in 
that report, the authors first designed peptides that folded into α-helices.  Next, they designed a loop 
to connect two of these helices.  In the final phase, the dimers were connected by another identical 
loop to yield a self-assembling four-helix bundle. 
Later, the development and characterization of the non-natural protein α2D marked the third 
generation of designed, dimerizing four-helix bundles from the DeGrado group.34  Initial 
characterization of this protein indicated a well-folded structure that was high in α-helical content.  
Additionally, α2D denatured cooperatively upon heating.  From this information, one would expect 
the protein to have self-associated in a nativelike manner.  However, when the solution structure 
was determined,35 it was discovered that α2D in fact dimerized as a “bisecting U,” a conformation 
not ordinarily found in nature. 
Rop as a model protein 
Cesareni et al. reported that a 63-residue protein was able to inhibit the binding of a specific 
primer RNA precursor to the ColE1 origin, thereby controlling the level of ColE1 replication in E. 
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coli.36  They dubbed this protein Repressor of Primer, or rop.  A communication by Banner et al. 
noted that rop was likely a dimer, and that the protein appeared to crystallize under a variety of 
conditions.37  The high-resolution structure was reported shortly thereafter;38 rop was an antiparallel, 
dimeric four-helix bundle composed almost entirely of α-helical content.  The solution structure 
reported later was in agreement with the crystal structure.39 
The large amount of high-resolution data for rop makes this protein an ideal choice for 
studying four-helix bundles.  The first mutagenesis experiments performed on rop were done to find 
its RNA-binding site.40  During their studies, the authors found that rop is surprisingly resiliant to 
surface mutations, despite being a relatively small protein. 
“Repacking” a core generally entails replacing the residues inside the hydrophobic region of 
a well-folded protein.  This is done in an effort to maintain the structural and stability characteristics 
of wild-type, but using a simplified inner region.  Repacking studies on rop were performed first by 
Munson et al.41  The authors treated rop’s core as eight layers of residues stacked by the protein’s α-
helical structure.  Constructs were made in which part or all of the core was redesigned such that 
each helix contributed only either Leu or Ala to the core.  These new variants were found to show 
similar results to wild-type rop upon biophysical characterization. 
Converting the normally dimeric rop into a single-chain monomer has also been an issue of 
interest.  As Predki et al. reported, a monomeric form would simplify mutational studies because 
variations on one side of the protein would not necessarily be conferred to the other side.42  Also, 
the successful design of a native-like, single-chain variant would yield the ability to rigorously 
compare the dimeric and monomeric interfaces.  Currently, one can examine separately monomers 
and dimers to see how they differ, but any deductions made would be inherently flawed because 
they compare different proteins.  However, by using a single-chain version of essentially the same 
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protein, one would be able to more accurately assess how residue mutations affect a dimeric 
interface versus a monomeric one. 
In the first attempt at single-chain rop, glycine chains were used to connect the helices.42  
The authors found that loop length was very important in preventing oligomerization, and that 
constructs of adequate loop lengths displayed cooperative unfolding.  Another group43 continued the 
study by choosing and optimizing appropriate loops from the Protein Data Bank.  From these 
experiments, they concluded that loop composition is also extremely important in creating a well-
folded structure. 
To replace the difficult gel-shift assays used to determine if a rop variant is functionally 
active, Magliery and Regan developed a cell-based assay that uses Green Fluorescent Protein as a 
reporter.44  As noted before, the function of rop is to regulate the copy number of ColE1 plasmid.  
By cloning GFP into a plasmid that uses a ColE1 origin, the authors were able to put rop directly in 
control of the amount of GFP expressed.  A functionally active variant would limit plasmid 
replication, thereby limiting fluorescence caused by GFP.  On the other hand, a misfolded rop 
variant would not be able to control plasmid replication; a high amount of GFP would result.  The 
application of this screen in high-throughput studies is apparent; one could feasibly assay the 
function of hundreds of rop variants on a single semisolid agar plate. 
Objectives 
1:  Synthesis and characterization of a cysteine-free rop 
 The cysteines present at positions 38 and 52 on the wild-type rop monomer present a 
challenge in library synthesis.  Normally not a problem in vivo due to the reducing environment 
of E. coli, these cysteines tend to form irreversible disulfide bonds within the hydrophobic core 
across the dimer.  This is especially problematic for destabilized library variants, which tend to 
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aggregate upon disulfide formation.  Thus, a cysteine-free rop variant that closely resembles the 
wild-type in structure and function would be extremely useful as a template for subsequent 
libraries. 
2:  Development and application of a novel high-throughput calorimetric assay 
 Library screening performed in vitro entails two distinct challenges: isolating each 
protein variant to homogeneity and finding a method to assay these variants.  In addition, both 
steps must be performed within a reasonable period of time.  Unlike binding assays such as 
beads and phage display, assays that probe stability are particularly challenging because they 
require relatively large amounts of protein.  Thus, one must be able to purify an adequate amount 
of protein from several orders of magnitude less culture than ordinarily used.  Regarding the 
assay itself, it should ideally be rapid and simple to perform.  Additionally, it would be 
inexpensive and require only readily accessible equipment. 
3:  Design and synthesis of single-chain rop variants 
 As noted before, the sixty-three-residue rop monomer forms an antiparallel homodimer to 
produce a well-packed hydrophobic core.  By synthetically moving and adding loops to connect 
each of rop’s four helices, it can be converted from a dimer to a single-chain monomer.  While 
rop monomers have previously been made by several groups, they were not done with the 
specific intent to conserve the structure, stability, and function of wild-type.  The variants aimed 
to be synthesized here would be designed with three unique qualities:  they would attempt to 
mimic the charge distribution seen in wild-type rop, be functionally active, and contain no 
cysteines. 
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Methods 
Objective 1:  Synthesis and characterization of a cysteine-free rop 
Gene construction (performed by C. Byeon).  Oligonucleotides were purchased (Sigma-
Genosys) to synthesize genes with point mutations at positions 38 and 52 of wild-type rop.  
These mutation combinations were Ala/Ala, Ser/Ser, Thr/Thr, and Val/Val.  The genes were 
constructed using the general method described by Stemmer.45  Briefly, the purchased 
oligonucleotides were designed to overlap in a complementary fashion by approximately 25 base 
pairs.  Upon PCR annealing and extension, these oligonucleotides should join and extend to form 
longer strands of DNA.  With enough overlapping fragments, entire genes are formed.  The gene 
of interest is amplified with flanking primers that also contain desired restriction and protease 
sites.  The oligonucleotides used to form these rop mutants are shown in Table 1.  Primers 1 and 
2 were used for all genes, while the third and fourth primers were specific to each variant.  Bold 
lettering indicates the point mutation. 
Table 1.  Primers used for cys-free rop mutant gene construction 
Primer Sequence (5’-3’) 
1 ATGACCAAACAGGAAAAAACCGCCCTTAACA 
TGGCCCGCTTTATCAGAAGCCAGACATTAAC 
2 CTGCCTGTTCATCCGCGTCCAGCTCGTTGAGT 
TTCTCCAGCAGCGTTAATGTCTGGCTTCTG 
3 Ala GACGCGGATGAACAGGCAGATATCGCGGAA 
TCGCTTCACGACCACGCTGATGAGCTTTACCG 
3 Ser GACGCGGATGAACAGGCAGATATTAGCGAA 
TCGCTTCACGACCACGCTGATGAGCTTTACCG 
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3 Val GACGCGGATGAACAGGCAGATATTGTGGAAT 
CGCTTCACGACCACGCTGATGAGCTTTACCG 
4 Ala TCAGAGGTTTTCACCGTCATCACCGAAACGCG 
CGAGCGCACTGCGGTAAAGCTCATCAGCG 
4 Ser TCAGAGGTTTTCACCGTCATCACCGAAACGCG 
CGAGGCTGCTGCGGTAAAGCTCATCAGCG 
4 Val TCAGAGGTTTTCACCGTCATCACCGAAACGCG 
CGAGCACACTGCGGTAAAGCTCATCAGCG 
PMR pro AATAATCCATGGCGCATCATCACCATCATCAC 
GGCGGTGAAAACCTGTATTTTCAGGGCACCAAACAGGAAAAAAC 
PMR term AATAATGGATCCTCAGAGGTTTTCACCGTC 
PAC pro AATAATAATCATATGACCAAACAGGAAAAAAC 
PAC term AATAATGGTACCTCAGAGGTTTTCACCGTC 
 
Cloning (performed by C. Byeon).  Each gene was amplified with two sets of primers to form 
“screening” genes that were used for the in vivo functional assay, and “expression” genes that 
contained N-terminal TEV- and His6-sites.  Screening genes (without TEV or His6 site) and pAC 
vector were digested with NcoI and BamHI (NEB), and expression genes and pMR vector were 
digested with NdeI and BanI.  Overnight ligation at 16 ºC was followed by transformation into 
electrocompetent DH10B, and recovered cells were plated and incubated overnight.  Picked 
colonies were grown in rich media, and the extracted DNA (Qiagen Miniprep) was sequenced 
(OSU PMGF). 
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Screening (performed by C. Byeon).  Genes in pAC vector were transformed into 
electrocompetent DH10B already containing the screening plasmid pUCBAD-GFPUV.44 
Cultures were plated onto semisolid LB media containing Amp/Kan/IPTG (0.1 mM)/arabinose 
(0.0005% w/v) and incubated overnight at 42 ºC.  Fluorescent cells were visualized by UV light. 
Protein purification.  Rop variants in pMR vectors were overexpressed in BL21(DE3) from 
colonies or glycerol stocks in 1 L 2YT media.  After induction to 0.1 mM IPTG at log phase, the 
cells were incubated for an additional 3 h at 37 ºC or overnight at 30 ºC.  Frozen, harvested cell 
pellets were resuspended in 25 mL lysis buffer (50 mM Tris-HCl pH 8, 300 mM NaCl, 10 mM 
imidazole), mixed with 5 mM MgCl2, 0.5 mM CaCl2, 5 µL Dnase I, 5 µL Rnase A, 0.1% Triton 
X-100, and 0.3-1 mg/mL HEW lysozyme, and allowed to incubate on ice for 30 min.  The 
solution was then sonicated at half power for 3x30 s with 2 min on ice in between pulses.  The 
cleared lysate was mixed on ice with 1 mL Ni-NTA (Qiagen) for 1 h.  The slurry was poured into 
a column, washed with wash buffer (lysis buffer with 20 mM imidazole), and the protein was 
eluted with elution buffer (lysis buffer with 250 mM imidazole).  TEV protease46 was added 
twice to the protein and incubated each time overnight at RT or 3 h at 30 ºC.  The solution was 
desalted with PD-10 columns (GE Amersham) and mixed with 1 mL Ni-NTA.  After incubating 
on ice for 1 h, the solution was added to a column, and the flow-through was collected to yield 
cleaved protein.  This protein was concentrated through a YM-3 filter (Millipore) and exchanged 
into appropriate buffer for subsequent analysis. 
CD spectroscopy.  Data was collected on an Aviv 202 Circular Dichroism Spectrometer.  Rop 
variants were analyzed at 50 µM monomer, as measured by UV absorption at 280 nm, and in CD 
buffer (50 mM sodium phosphate pH 6.3, 300 mM NaCl).  Thermal denaturations were acquired 
at 1 °C min-1, 25 to 90ºC, at 222 nm.  Urea denaturations were performed in the same conditions 
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but using varying concentrations of urea, with spectra acquired after equilibrating 24-48 h at RT, 
at 222 nm. 
NMR.  Rop was purified as above, but using minimal media with 15N-labeled NH4Cl as the 
nitrogen source.  The purified protein was exchanged into CD buffer, concentrated, and finally 
mixed with 10% D2O directly before analysis.  1H- and 15N-HSQC spectra were acquired on a 
600 MHz Bruker NMR with inverse probe using standard Lewis E. Kay pulse sequences. 
Crystal growth.  Rop was purified as above, but was followed by a gel filtration purification 
using a Superdex 75 10/300 GL column (GE Tricorn).  The protein was then exchanged into 
mild buffer (10 mM PIPES pH 6.3, 50 mM NaCl) and concentrated, if necessary, to 
approximately 2 mg/mL as determined by Bradford assay.  Sitting drop and hanging drop trials 
were performed.  Plates were obtained from both ammonium sulfate and MPD.  Large prisms 
were obtained from hanging drop wells using 1-mL reservoirs containing 25-30% methanol, 
MES (100 mM pH 5.7-5.9), NaCl (300 mM), and glycerol (10%).  Rhomboidal prisms appeared 
overnight at 22 ºC and grew for 3-5 days. 
Crystal analysis.  Diffraction data was collected on a Rigaku R-AXIS IV++ at –160 ºC and a 
detector distance of 200 mm.  Images were collected at 0.5º increments with exposure times of 2 
min.  Integration was performed by d*TREK.47 Molecular replacement modelling and building 
was done using the Phenix suite24 and Phaser.48  Refinement was performed using Coot49 
(including REFMAC550) and Phenix.refine24 
Objective 2:  Development and application of a novel high-throughput calorimetric assay 
Protein purification.  2YT rich media (1.5 mL) was inoculated with rop variants from colonies of 
DH10B(DE3) and grown overnight to saturation in 96-well deepwell plates (USA Scientific).  
Cultures were diluted to log-phase (OD600 ~0.8) and a volume of 2 mL, induced with 10 µM 
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IPTG, and grown overnight at 30 °C (described by Chae et al.)51.  Harvested cell pellets were 
frozen at –80 °C for at least 1 h, then resuspended in lysis buffer.  Lysis was performed by 
mixing lysates with DNase, RNase, lysozyme, and PopCulture reagent (Novagen), then 
incubating at RT for 30 min.  Cleared lysates were mixed with 50 µL Ni-NTA magnetic agarose 
beads (Qiagen) and incubated at RT for 1 h.  The beads were washed twice with wash buffer, 
then resuspended in 25 µL lysis buffer.  On-column TEV cleavage was performed by adding 11 
mM βME and 0.5 µL TEV protease and incubating at RT overnight with occasional agitation 
during the first few hours.  The magnetic beads were removed, and the cleaved, purified protein 
was ready for further analysis. 
Screening.  Protein solution (19 µL) was mixed with 1 µL Sypro Orange (Invitrogen) to achieve 
a final concentration of 15x dye from a stock of 5000x.  Melts were performed in RT-PCR plates 
on a Bio-Rad iCycler iQ Real-Time Detection System (OSU PMGF) set to increase temperature 
at a rate of 1 °C-min-1.  Excitation/emission wavelengths were set to 490/575 nm. 
Objective 3:  Design and synthesis of single-chain rop variants 
Gene construction.  Two single-chain mutants, MPP and PMP rop, were designed using the 
topologies shown in Figure 1.43  Loops were designed by first principles in an effort to contain a 
reasonable amount of flexibility and solubility.  PCR was performed as described in Objective 1.  
Oligonucleotide design for PMP rop used the method described by Gao.52  Tables 2 and 3 show 
the oligonucleotides used for MPP and PMP rop syntheses, respectively.  Flanking primers at the 
5’ end containing AflIII restriction sites for PMR and PAC vectors were kindly provided by J. 
Lavinder. 
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Figure 1.  Topologies of MPP (left) and PMP rop 
    
Table 2.  Primers used for single-chain MPP rop mutant gene construction 
Primer Sequence (5’-3’) 
1 ATGACCAAACAGGAAAAAACTGCTCTCAACATGGCGCGTTTCAT 
2 TCTCAACATGGCGCGTTTCATTCGTAGTCAGACCCTGACACTGCT 
3 TAGTCAGACCCTGACACTGCTGGAGAAGCTGAACGAACTGGATGC   
4 GAAGCTGAACGAACTGGATGCTGATGAACAGGCAGATATCGCGGA   
5 GAACAGGCAGATATCGCGGAGAGTCTTCACGACCATGCGGACGAA   
6 CTTCACGACCATGCGGACGAATTGTATCGAAGTGTGCTGGCGCGGTT   
7 GAAGTGTGCTGGCGCGGTTCGATGGAGATGATGAGCAGGCCGACATA  
8 GCGTGATCATGTAGACTTTCAGCTATGTCGGCCTGCTCATCATCT   
9 AACACCGAACGGTACAGTTCATCTGCGTGATCATGTAGACTTTCAGC   
10 TTATCTCCATCAAAGCGCGCCAACACCGAACGGTACAGTTCATCT   
11 CATATTCAGCGCCGTTTTTTCCTGTTTATCTCCATCAAAGCGCGCC   
12 TTGCGACCGTATAAACCGTGCCATATTCAGCGCCGTTTTTTCCTG   
13 CAGTTTTTCAAGCAGAGTCAGTGTTTGCGACCGTATAAACCGTGC   
14 TTATTTCAACTCATTCAGTTTTTCAAGCAGAGTCAGTGT   
PMR-3’ AATAATGGATCCTTATTTCAACTCATTCAGTTTTTCAAG 
PAC-3’ AATAATGGTACCTTATTTCAACTCATTCAGTTTTTCAAG 
 
Table 3.  Primers used for single-chain PMP rop mutant gene construction 
Primer Sequence (5’-3’) 
1 ATGACCAAACAGGAGAAAACGGCGCTTAACA 
2 GCTCCGAATGAATCGTGCCATGTTAAGCGCCGTTTTTTCCTGTTT   
3 GGCACGATTCATTCGGAGCCAGACCCTTACTCTCCTAGAAAAACT   
4 TGCCGCTGTTCAGCTCGTTCAGTTTTTCTAGGAGAGTAAGGGTCT   
5 AACGAGCTGAACAGCGGCACGAAACAGGAAAAGACGGCACTGAAC  
6 TTGACTACGAATAAAACGCGCCATGTTCAGTGCCGTCTTTTCCTGT   
7 GGCGCGTTTTATTCGTAGTCAAACCCTGACGCTGCTGGAGAAGCT   
8 TGTTCATCCGCATCCAGTTCATTCAGCTTCTCCAGCAGCGTCAGG   
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9 TGAACTGGATGCGGATGAACAAGCAGACATCGCGGAAAGCCTGCA   
10 GGTAAAGTTCGTCAGCGTGGTCATGCAGGCTTTCCGCGATGTCT 
11 TGACCACGCTGACGAACTTTACCGGAGTGTGCTTGCACGTTTTGA   
12 TGTCCGCCTGCTCGTCATCTCCATCAAAACGTGCAAGCACACTCC   
13 GATGACGAGCAGGCGGACATAGCGGAGAGTTTGCATGATCACGCC   
14 AGCACACTACGGTACAGCTCATCGGCGTGATCATGCAAACTCTCC   
15 TGAGCTGTACCGTAGTGTGCTGGCTCGCTTTGGTGATGATGGAGA   
16 TTACAGATTTTCTCCATCATCACCAAAGCGAG   
PMR-3’ AATAATGGATCCTTACAGATTTTCTCCATCATCACC 
PAC-5’ AATAATGGTACCTTACAGATTTTCTCCATCATCACC 
 
Cloning.  Amplification was performed as described in Objective 1.  Screening genes and PMR 
vector were digested with AflIII and BamHI (NEB), and expression genes and PAC vector were 
digested with AflIII and BanI.  Overnight ligation at 16 ºC was followed by background 
digestion with EcoRI and NdeI for PMR vector and EcoRI and NcoI for PAC vector.  The 
purified plasmids were transformed into electrocompetent DH10B, and recovered cells were 
plated and incubated overnight.  Picked colonies were grown in rich media, and the extracted 
DNA (Qiagen Miniprep) was sequenced (Genewiz). 
Screening and protein purification were performed as described in Objective 1.  CD 
spectroscopy was performed at 25 µM single-chain monomer. 
Results and Discussion 
Objective 1:  Synthesis and characterization of a cysteine-free rop 
 Figure 2 shows the results of the functional GFP screen performed on the sythesized cys-
free rop constructs.  It should be noted that the positive screen was used for this experiment, 
which displays an inverse phenotype of the negative screen.  It is readily seen that only Ser/Ser is 
not active in vivo.  “Link” is a negative control which does not contain a rop gene. 
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Figure 2.  Functional screen on cys-free rop constructs 
 
Of the active constructs, only Ala/Val (AV) rop was soluble as an overexpressed His6-fusion 
protein.  CD wavelength scans (Figure 3) show that AV rop has approximately the same amount 
of α-helical character as wild-type.  Additionally, thermal melts (Figure 4) show that AV rop is 
slightly more stable thermodynamically than wild-type.  Interestingly, AV rop is not nearly as 
stable by chemical denaturation methods (Figure 5).  Unfolding in the presence of high urea 
concentrations is approximately 1 h, while the same conditions take several days for wild-type. 
Link 
Ala/Val 
Val/Val Ser/Ser 
Ala/Ala 
WT 
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Figure 3.  Wavelength scans of AV and wild-type rop 
 
Figure 4.  Thermal melts of AV and wild-type rop 
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Figure 5.  Rates of unfolding for AV and wild-type rop in urea 
 
The HSQC NMR spectrum of AV rop (Figure 6) is very similar to wild-type53 (ITLA).  Peaks 
are clear and well-dispersed, indicating a folded structure. 
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Figure 6.  15N-HSQC NMR spectra of AV (top) and wild-type rop 
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Figure 7 is a sample of the AV crystals obtained with methanol as a precipitant.  The prisms 
were large, and visible deformities did not seem to have any adverse effects on diffraction 
quality.  Figure 8 is the crystal structure of AV rop overlaid on the wild-type structure.  The AV 
structure has not been fully refined at the time of this writing, but the results after molecular 
replacement phasing and modelling are shown in the figure.  The RMSD between the structures 
is 0.37 Å (as determined by SUPER in Pymol)54.  Electron density maps show very few areas 
that are in need of refinement. 
Figure 7.  Crystals of AV rop 
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Figure 8.  Crystal structure of AV rop (blue) overlaid on wild-type (red) 
 
Objective 2:  Development and application of a novel high-throughput calorimetric assay 
 It was determined that enough protein could be purified from 2 mL cultures to perform 
our High-throughput Calorimetry assay.  Additionally, the use of DH10B(DE3) allowed protein 
overexpression and high plasmid replication from the same cell line.  This obviated an additional 
transformation step for DNA sequencing.  Also, the assay seems to produce excellent results.  
Figure 9 shows three variants screened as controls for the method.  LMLL, a highly destabilized 
variant, binds to the dye immediately.  On the other hand, wild-type and AV rop exclude the dye 
from their hydrophobic cores until they unfold. 
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Figure 9.  Controls used for High-throughput Calorimetry 
 
Figure 10 illustrates the throughput of our new calorimetric method; it shows the melt results of 
dozens of native-like variants from a small rop library which mutates four of the residues in its 
hydrophobic core. 
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Figure 10.  High-throughput Calorimetry results from native-like variants in a rop library 
 
 
Objective 3:  Design and synthesis of single-chain rop variants 
 Both constructs, MPP and PMP rop, are functionally active, shown by the GFP screen in 
Figure 11.  However, MPP rop appears to be proteolyzed at one of the loop regions, resulting in 
both full-length and a truncated product (data not shown).  Regardless, PMP rop contains a high 
level of α-helical content, and its urea melt curve indicates cooperativity (Figures 12 and 13).  Its 
thermal melt (Figure 14), however, shows that no refolding occurs, unlike most other native-like 
dimeric rop constructs. 
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Figure 11.  In-cell GFP screen of MPP and PMP single-chain rop variants 
 
Figure 12.  Wavelength CD scan of PMP rop 
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Figure 13.  Urea melt curve of PMP rop 
 
Figure 14.  Thermal melt curve of PMP rop 
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Remarks 
 A novel, cysteine-free variant of wild-type rop has been extensively characterized.  High-
resolution data shows that this new A38/V52 mutant is very similar to the wild-type structure 
and maintains its function in vivo. 
 A method for purifying protein variants on a high-throughput scale has been developed 
and applied to a small library.  These variants have also been screened using our newly-
developed High-throughput Calorimetry assay, which has shown to be able to characterize 
proteins rapidly for stability. 
 Two new single-chain rop variants have been synthesized and characterized to show that 
both are functionally active in vivo, and one has a high degree of α-helical content and shows 
cooperativity in unfolding. 
 Future work will likely entail synthesizing single-chain rop libraries which randomize the 
loop positions in an effort to find more stable variants.  These variants will be found by High-
throughput Calorimetry and further characterized by NMR spectroscopy and x-ray 
crystallography.  
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